过敏原免疫疗法:对肺功能有效吗?
相关实验视频
Updated: Jan 17, 2026

07:22
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
9.3K
Edoardo Cavaglià1,2, Maurizio Marogna3, Giovanni Paoletti1,2
1Department of Biomedical Sciences, Humanitas University, Pieve Emanuele.
Current opinion in allergy and clinical immunology
|September 18, 2025
概括
过敏原免疫疗法 (AIT) 显示出持续性喘益处的潜力,并可能改善肺功能,但强有力的长期证据仍然有限. 需要进一步的研究来确认其在改变喘进展中的作用.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 过敏 过敏是一种过敏.
背景情况:
- 喘管理正在向针对2型炎症的疾病修饰策略发展.
- 过敏原免疫疗法 (AIT) 是对过敏性疾病的关键干预措施.
- 了解AIT对喘进展的长期影响至关重要.
研究的目的:
- 审查对过敏原免疫治疗对喘患者肺功能影响的证据.
- 专注于喘患者AIT的长期结果.
- 评估AIT在喘疾病修饰中的潜在作用.
主要方法:
- 对观察性和随机对照研究的系统审查.
- 分析临床益处,喘控制,恶化率和肺功能.
- 包括最近的现实世界前性研究.
主要成果:
- 语言下免疫疗法 (SLIT) 可能提供持续的临床益处和对肺功能的积极影响.
- 观察到喘控制和减轻恶化情况的持续改善.
- 对长期肺功能保护的有力证据是有限的;一些研究表明对FEV1.1的过敏原独立益处.
结论:
- AIT被确认为一种针对过敏症的疾病修饰治疗方法.
- 对于AIT能够预防或减缓喘中的肺功能下降的能力,需要进一步研究.
- 未来的研究应该集中在各种过敏原和人群的纵向螺旋测量数据上,以澄清AIT在喘进展中的作用.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Antiasthma Drugs: Leukotriene Modifiers
1.8K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.8K
Allergic Reactions
32.1K
Overview
32.1K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Drugs Used in Lower Respiratory Disorders: Overview
1.1K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.1K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K

